Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies.
Sci Transl Med. Feb 19 2014;6(224):224ra224. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017867/. Accessed April 20, 2020.
Butler TM, Spellman PT, Gray J. Circulating-tumor DNA as an early detection and diagnostic tool. Curr Opin Genet Devel. February 2017;42:14-21.
Contreras-Naranjo JC, Wu HJ, Ugaz VM. Microfluidics for exosome isolation and analysis-enabling liquid biopsy for personalized medicine. Lab Chip. 2017;17:3558-3577.
Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. August 2013;10(8):472-484.
Dressman D, Yan H, Traverso G, KInzler KW, Vogelstein B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations.
Proc Natl Acad Sci U S A. July 22, 2003;100(15):8817–8822. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166396/. Accessed April 20, 2020.
Gingras I, Salgado R, Ignatiadis M. Liquid biopsy: will it be the ‘magic tool’ for monitoring response of solid tumors to anticancer therapies? Current Opinion in Oncology. November 2015;27(6):560-567.
Kinde I, Wu J, Papadopoulos N, Kinzler KW, Vogelstein B. Detection and quantification of rare mutations with massively parallel sequencing.
Proc Natl Acad Sci U S A. June 7, 2011;108(23): 9530–9535. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111315/. Accessed April 20, 2020.
Lecomte T, Berger A, Zinzindohoue F, Micard S, Landi B, et al. Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.
Inter J Cancer. June 19, 2002;100(5): 542–548. Available at:
http://onlinelibrary.wiley.com/doi/10.1002/ijc.10526/full. Accessed April 20, 2020.
Mao C, Yuan JQ, Yang ZY, Fu XH, Wu XY, et al. Blood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Medicine. May 2015;94(21):e775. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616411/. Accessed April 20, 2020.
Pailler E, Adam J, Barthelemy A, Oulhen M, Auger N, et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
J Clin Oncol. Jun 20, 2013;31(18):2273-2281. Available at:
https://www.ncbi.nlm.nih.gov/pubmed/23669222. Accessed April 20, 2020.
Perez-Callejo D, Romero A, Provencio M, Torrente M. LIquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.
Transl Lung Cancer Res. 2016;5(5):455-465. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099509/. Accessed April 20, 2020.
Perkins G, Yap TA, Pope L, Cassidy AM, Dukes JP, et al. Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers.
PloS One. 2012;7(11): e47020. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492590/. Accessed April 20, 2020.
Qiu M, Wang J, Xu Y, Ding X, Li M, et al. Circulating Tumor DNA is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis.
Cancer Epidemiol Biomarkers Prev. Jan 2015;24(1):206-212. Available at:
http://cebp.aacrjournals.org/content/24/1/206.long. Accessed April 20, 2020.
Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, Leyland-Jones B, et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500.
J Clin Oncol. November 1, 2014;32(31):3483-3489. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209100/. Accessed April 20, 2020.
Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. September 2006;24(26):4270–4276.
Vallée A, Marcq M, Bizieux A, Kouri C, Lacroix H, et al. Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients. Lung Cancer. November 2013;82(2):373–374.
van der Pol E, Böing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharm Rev. July 2012;64(3):676–705. Available at:
http://pharmrev.aspetjournals.org/content/64/3/676. Accessed April 20, 2020.
Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews Cancer. February 24, 2017;7:223-238.